Lantern Pharma Inc. (LTRN) AI Dilution Summary

Estimated cash was $8,020,342 as of 2026-09-30, rolled forward from $7,361,255 at 2026-06-30 against estimated monthly burn of $980,304. The most recent capital raised was a registered direct offering closed 2026-09-30 through Rodman & Renshaw LLC: $3,999,780.25 gross and $3,600,000 net as filed, for 1,469,725 shares at $1.09 plus pre-funded warrants. Dilution here is driven primarily by the active S-3 shelf.